CANY
CL icon

Caxton Associates (New York)’s Colgate-Palmolive CL Stock Holding History

Caxton Associates (New York)’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-50,000
Closed -$3.64M – 360
2017
Q3 		$3.64M Hold
50,000
– – 0.13% 148
2017
Q2 		$3.71M Buy
+50,000
New +$3.71M 0.14% 160

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Caxton Associates (New York)'s CL Position: Q4 2023 in Review

Caxton Associates (New York) sold out of Colgate-Palmolive (CL) in Q4 2023, closing a stake of 3,076 shares — an estimated $219K sold.

Caxton Associates (New York) first reported a position in CL in Q3 2016 and held it in 15 quarters. The position peaked at $17.8M in Q3 2016. 1,741 funds tracked by Wall St. Rank hold CL as of Q4 2023.

  • Caxton Associates (New York) reported no remaining Colgate-Palmolive position as of Q4 2023 after selling out during the quarter.
  • Caxton Associates (New York) sold 3,076 Colgate-Palmolive shares in Q4 2023, an estimated $219K.
  • Caxton Associates (New York) first reported a position in Colgate-Palmolive in Q3 2016 and held it in 15 quarters.
  • Caxton Associates (New York)'s Colgate-Palmolive position peaked at $17.8M in Q3 2016.
  • 1,741 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2023.

Based on Caxton Associates (New York)'s 13F filing for Q4 2023, filed 14 Feb 2024.